Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1992 May;67(5):603-7.
doi: 10.1136/adc.67.5.603.

Intensive enteral feeding in advanced cirrhosis: reversal of malnutrition without precipitation of hepatic encephalopathy

Affiliations
Clinical Trial

Intensive enteral feeding in advanced cirrhosis: reversal of malnutrition without precipitation of hepatic encephalopathy

C P Charlton et al. Arch Dis Child. 1992 May.

Abstract

Ten children with advanced cirrhosis and malnutrition (less than 90% weight for height) were fed for eight weeks with a nasogastric feed comprising whey protein (enriched with branched chain amino acids), fat as 34% medium chain and 66% long chain triglycerides, and glucose polymer. Six of the children were studied for an eight week control period before feeding. Weight, triceps skinfold thickness, mid-arm circumference, mid-arm muscle area, and fasting plasma ammonia and amino acid concentrations were measured before and after the control period and after the consequent feed period. Results showed that despite high energy and protein intakes the children remained malnourished over the control period. All anthropometric indices improved significantly during the feed period, and no child developed clinical encephalopathy. The feed period was associated with a small, and not clinically significant, increase in the plasma ammonia concentration, but no consistent trend in the plasma amino acid concentrations. Thus, in children with advanced hepatobiliary disease awaiting liver transplantation, enteral feeding improved nutritional status without adverse clinical or biochemical effects.

PubMed Disclaimer

References

    1. J Am Coll Nutr. 1985;4(6):639-50 - PubMed
    1. J Pediatr Gastroenterol Nutr. 1987 Nov-Dec;6(6):860-4 - PubMed
    1. Lancet. 1983 Mar 26;1(8326 Pt 1):688-91 - PubMed
    1. Lancet. 1980 Sep 20;2(8195 pt 1):615-7 - PubMed
    1. Am J Clin Nutr. 1981 Nov;34(11):2540-5 - PubMed

Publication types

LinkOut - more resources